Sarah P. Psutka: Grateful to be part of this incredible international community of UroOncs
Shilpa Gupta shared a post by Sarah P. Psutka, Associate Editor at European Urology, on X:
“Thanks Morgan Roupret, Arnulf Stenzl for such a fantastic UroOnco24 meeting! Loved the short talks format and discussions around pertinent and controversial clinical topics!
Grateful for my amazing women in Genitourology.“.
Quoting Sarah P. Psutka‘s post:
“A massive thanks to the organizers of the UROonco24 mtg in stunning Budapest ! Congrats on a phenomenal program! I’m so grateful to be part of this incredible international community of UroOncs.”
Source: Shilpa Gupta/X and Sarah P. Psutka/X
Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023